Colleen Maher

405 total citations
12 papers, 80 citations indexed

About

Colleen Maher is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Colleen Maher has authored 12 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Colleen Maher's work include Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (4 papers) and CAR-T cell therapy research (3 papers). Colleen Maher is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (4 papers) and CAR-T cell therapy research (3 papers). Colleen Maher collaborates with scholars based in United States, Denmark and United Kingdom. Colleen Maher's co-authors include Michael A. Postow, Margaret K. Callahan, Patrick Schöffski, Anna Spreafico, Ayushi Gupta, Scott Antonia, Ani Sarkis Balmanoukian, Samir N. Khleif, Marlon C. Rebelatto and Dan P. Zandberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Colleen Maher

10 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colleen Maher United States	5	64	24	22	13	12	12	80
Hongqian Wu United States	4	93 1.5×	29 1.2×	28 1.3×	7 0.5×	7 0.6×	6	121
Brian Hunis United States	6	57 0.9×	16 0.7×	41 1.9×	33 2.5×	24 2.0×	28	111
Carl Cook United States	8	93 1.5×	24 1.0×	41 1.9×	6 0.5×	11 0.9×	12	137
Carly Reeder United States	2	102 1.6×	67 2.8×	18 0.8×	8 0.6×	7 0.6×	3	121
Lucile Vanhersecke France	5	105 1.6×	63 2.6×	38 1.7×	9 0.7×	10 0.8×	17	133
Xuede Lin United States	5	54 0.8×	44 1.8×	10 0.5×	8 0.6×	12 1.0×	9	84
Leah Ensell United Kingdom	6	107 1.7×	14 0.6×	28 1.3×	5 0.4×	24 2.0×	12	129
Gustavo Dix Junqueira Pinto Brazil	4	50 0.8×	8 0.3×	45 2.0×	12 0.9×	28 2.3×	5	84
Cristina Viaplana Spain	5	64 1.0×	23 1.0×	34 1.5×	7 0.5×	16 1.3×	19	82
Helmut Lambertz Germany	4	81 1.3×	25 1.0×	28 1.3×	8 0.6×	8 0.7×	4	99

Countries citing papers authored by Colleen Maher

Since Specialization

Citations

This map shows the geographic impact of Colleen Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Maher more than expected).

Fields of papers citing papers by Colleen Maher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Maher. The network helps show where Colleen Maher may publish in the future.

Co-authorship network of co-authors of Colleen Maher

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Maher. A scholar is included among the top collaborators of Colleen Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Maher. Colleen Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Smithy, James W., Andrea P. Moy, Colleen Maher, et al.. (2025). Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma. Cell Reports. 44(4). 115554–115554. 1 indexed citations

Gupta, Aditi, Karissa Whiting, Niamh M. Keegan, et al.. (2024). Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO).. Journal of Clinical Oncology. 42(16_suppl). 4569–4569.

Smithy, James W., Colleen Maher, Alexander N. Shoushtari, et al.. (2023). Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT).. Journal of Clinical Oncology. 41(16_suppl). 9517–9517.

Adamow, Matthew, Colleen Maher, Michael A. Postow, et al.. (2023). A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy. Cell Reports Methods. 3(8). 100546–100546. 3 indexed citations

Vanguri, R., James W. Smithy, Yanyun Li, et al.. (2023). Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma. The Journal of Pathology. 261(3). 349–360. 6 indexed citations

Smithy, James W., Yanyun Li, Andrea P. Moy, et al.. (2023). 1303 Spatial topic modeling of tumor microenvironment with multiplexed imaging. SHILAP Revista de lepidopterología. A1448–A1448. 1 indexed citations

Luo, Jia, Song Wu, Hira Rizvi, et al.. (2022). Deciphering radiological stable disease to immune checkpoint inhibitors. Annals of Oncology. 33(8). 824–835. 24 indexed citations

Smithy, James W., Matthew J. Pianko, Colleen Maher, et al.. (2020). Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia. Journal of Immunotherapy. 44(1). 9–15. 9 indexed citations

Funt, Samuel A., Anne-Mette Bjerregaard, James L. Reading, et al.. (2020). Interrogation of neoantigen-specific CD8 T cells in peripheral blood following PD-L1 blockade in patients with metastatic urothelial carcinoma (mUC).. Journal of Clinical Oncology. 38(15_suppl). 3075–3075. 1 indexed citations

10.

Keegan, Niamh M., Samuel A. Funt, Brooke Kania, et al.. (2019). Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC).. Journal of Clinical Oncology. 37(7_suppl). 481–481. 4 indexed citations

11.

Santomasso, Bianca, Aya Haggiagi, Rachna Malani, et al.. (2018). Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade.. Journal of Clinical Oncology. 36(15_suppl). 3084–3084. 1 indexed citations

12.

Segal, Neil H., S.‐H.I. Ou, Ani Sarkis Balmanoukian, et al.. (2016). Updated safety and efficacy of durvalumab (MEDI4736), an anti-PD-L 1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort. Annals of Oncology. 27. vi328–vi328. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact